![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
* The National Institute of Health and Nutrition, 1–23-1 Toyama, Shinjuku-ku, Tokyo 162-8636, Japan;
Takasaki University of Health and Welfare, 37–1 Nakaorui, Takasaki, Gunma 370-0033, Japan and
** CSIRO Health Sciences and Nutrition, Adelaide BC, Adelaide, SA, Australia 5000
1To whom correspondence should be addressed. E-mail: michael.fenech{at}csiro.au.
We tested the hypothesis that methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism, folic acid deficiency and riboflavin deficiency, independently or interactively, are important determinants of genomic stability, cell death, cell proliferation and homocysteine (Hcy) concentration in 9-d human lymphocyte cultures. Lymphocytes of seven wild-type (CC) and seven mutant (TT) homozygotes were cultured under the four possible combinations of deficiency and sufficiency of riboflavin (0 and 500 nmol/L) and folic acid (20 and 100 nmol/L) at a constant L-methionine concentration of 50 µmol/L. Viable cell growth was 25% greater in TT than in CC cells (P < 0.05) and 32% greater at 100 nmol/L folic acid than at 20 nmol/L folic acid (P = 0.002). The comprehensive cytokinesis-block micronucleus assay was used to measure micronuclei (MNi; a marker for chromosome breakage and loss), nucleoplasmic bridges (NPB; a marker of chromosome rearrangement) and nuclear buds (NBUD, a marker of gene amplification). The MNi levels were 21% higher in TT cells than in CC cells (P < 0.05) and 42% lower in the high folic acid medium than in the low folic acid medium (P < 0.0001). The NBUD levels were 27% lower in TT cells than in CC cells (P < 0.05) and 45% lower in the high folic acid medium than in the low folic acid medium (P < 0.0001). High riboflavin concentration (500 nmol/L) increased NBUD levels by 25% (compared with 0 nmol/L riboflavin) in folate-deficient conditions (20 nmol/L folic acid medium; P < 0.05), and there was an interaction between folic acid and riboflavin that affected NBUD levels (P = 0.042). This preliminary investigation suggests that MTHFR C677T polymorphism and riboflavin affect genome instability; however, the effect is relatively small compared with that of folic acid.
This article has been cited by other articles:
|
|
 |
|
  J. Wu, G. H. Lyons, R. D. Graham, and M. F. Fenech The effect of selenium, as selenomethionine, on genome stability and cytotoxicity in human lymphocytes measured using the cytokinesis-block micronucleus cytome assay Mutagenesis, May 1, 2009; 24(3): 225 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Benassi-Evans, P. M. Clifton, M. Noakes, J. B. Keogh, and M. Fenech High protein-high red meat versus high carbohydrate weight loss diets do not differ in effect on genome stability and cell death in lymphocytes of overweight men Mutagenesis, May 1, 2009; 24(3): 271 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Beetstra, G. Suthers, V. Dhillon, C. Salisbury, J. Turner, M. Altree, R. McKinnon, and M. Fenech Methionine-Dependence Phenotype in the de novo Pathway in BRCA1 and BRCA2 Mutation Carriers with and without Breast Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2565 - 2571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bonassi, H. Norppa, M. Ceppi, U. Stromberg, R. Vermeulen, A. Znaor, A. Cebulska-Wasilewska, E. Fabianova, A. Fucic, S. Gundy, et al. Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries Carcinogenesis, June 1, 2008; 29(6): 1178 - 1183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-y. Liu, Y.-H. Hsu, P.-C. Pan, M.-T. Wu, C.-K. Ho, L. Su, X. Xu, Y. Li, D. C. Christiani, and the Kaohsiung Leukemia Research Group Maternal and offspring genetic variants of AKR1C3 and the risk of childhood leukemia Carcinogenesis, May 1, 2008; 29(5): 984 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bonassi, A. Znaor, M. Ceppi, C. Lando, W. P. Chang, N. Holland, M. Kirsch-Volders, E. Zeiger, S. Ban, R. Barale, et al. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans Carcinogenesis, March 1, 2007; 28(3): 625 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.T. Dobson, R.M. Davis, M.P. Rosen, S. Shen, P.F. Rinaudo, J. Chan, and M.I. Cedars Methylenetetrahydrofolate reductase C677T and A1298C variants do not affect ongoing pregnancy rates following IVF Hum. Reprod., February 1, 2007; 22(2): 450 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Boffetta, O. van der Hel, H. Norppa, E. Fabianova, A. Fucic, S. Gundy, J. Lazutka, A. Cebulska-Wasilewska, D. Puskailerova, A. Znaor, et al. Chromosomal Aberrations and Cancer Risk: Results of a Cohort Study from Central Europe Am. J. Epidemiol., January 1, 2007; 165(1): 36 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Leopardi, F. Marcon, S. Caiola, A. Cafolla, E. Siniscalchi, A. Zijno, and R. Crebelli Effects of folic acid deficiency and MTHFR C677T polymorphism on spontaneous and radiation-induced micronuclei in human lymphocytes Mutagenesis, September 1, 2006; 21(5): 327 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. El-Zein, M. B. Schabath, C. J. Etzel, M. S. Lopez, J. D. Franklin, and M. R. Spitz Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res., June 15, 2006; 66(12): 6449 - 6456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Beetstra, C. Salisbury, J. Turner, M. Altree, R. McKinnon, G. Suthers, and M. Fenech Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency Carcinogenesis, March 1, 2006; 27(3): 517 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, X. Wu, Z. Liang, Y. Huang, M. Fenech, and J. Xue A comparison of folic acid deficiency-induced genomic instability in lymphocytes of breast cancer patients and normal non-cancer controls from a Chinese population in Yunnan Mutagenesis, January 1, 2006; 21(1): 41 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Powers Interaction among Folate, Riboflavin, Genotype, and Cancer, with Reference to Colorectal and Cervical Cancer J. Nutr., December 1, 2005; 135(12): 2960S - 2966S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fenech The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis Mutagenesis, July 1, 2005; 20(4): 255 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. van den Donk, B. Buijsse, S. W. van den Berg, M. C. Ocke, J. L. Harryvan, F. M. Nagengast, F. J. Kok, and E. Kampman Dietary Intake of Folate and Riboflavin, MTHFR C677T Genotype, and Colorectal Adenoma Risk: A Dutch Case-Control Study Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1562 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fenech, P. Baghurst, W. Luderer, J. Turner, S. Record, M. Ceppi, and S. Bonassi Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, {beta}-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability--results from a dietary intake and micronucleus index survey in South Australia Carcinogenesis, May 1, 2005; 26(5): 991 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Smolkova, M. Dusinska, K. Raslova, M. Barancokova, A. Kazimirova, A. Horska, V. Spustova, and A. Collins Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk Mutagenesis, November 1, 2004; 19(6): 469 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Narayanan, J. McConnell, J. Little, L. Sharp, C. J. Piyathilake, H. Powers, G. Basten, and S. J. Duthie Associations between Two Common Variants C677T and A1298C in the Methylenetetrahydrofolate Reductase Gene and Measures of Folate Metabolism and DNA Stability (Strand Breaks, Misincorporated Uracil, and DNA Methylation Status) in Human Lymphocytes In vivo Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1436 - 1443. [Abstract] [Full Text] [PDF]
|
|
